Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study.

Siami K, Kojouri K, Swisher KK, Selby GB, George JN, Laszik ZG.

Transplantation. 2008 Jan 15;85(1):22-8. doi: 10.1097/01.tp.0000297998.33418.7e.

PMID:
18192907
2.

Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.

Uderzo C, Bonanomi S, Busca A, Renoldi M, Ferrari P, Iacobelli M, Morreale G, Lanino E, Annaloro C, Volpe AD, Alessandrino P, Longoni D, Locatelli F, Sangalli H, Rovelli A.

Transplantation. 2006 Sep 15;82(5):638-44.

PMID:
16969286
3.

Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation.

Kojouri K, George JN.

Curr Opin Oncol. 2007 Mar;19(2):148-54. Review.

PMID:
17272988
4.

Clinicopathologic analysis of renal biopsies after haematopoietic stem cell transplantation.

Chan GS, Lam MF, Au WY, Chim S, Tse KC, Lo SH, Fung SH, Lai KN, Chan KW.

Nephrology (Carlton). 2008 Jun;13(4):322-30. doi: 10.1111/j.1440-1797.2007.00915.x. Epub 2008 Jan 23.

PMID:
18221254
5.

Renal pathology at autopsy in patients who died after hematopoietic stem cell transplantation.

El-Seisi S, Gupta R, Clase CM, Forrest DL, Milandinovic M, Couban S.

Biol Blood Marrow Transplant. 2003 Nov;9(11):683-8.

6.

Spectrum of renal pathology in hematopoietic cell transplantation: a series of 20 patients and review of the literature.

Chang A, Hingorani S, Kowalewska J, Flowers ME, Aneja T, Smith KD, Meehan SM, Nicosia RF, Alpers CE.

Clin J Am Soc Nephrol. 2007 Sep;2(5):1014-23. Epub 2007 Jul 11. Review.

7.

Ocular findings after allogeneic hematopoietic stem cell transplantation.

Tabbara KF, Al-Ghamdi A, Al-Mohareb F, Ayas M, Chaudhri N, Al-Sharif F, Al-Zahrani H, Mohammed SY, Nassar A, Aljurf M.

Ophthalmology. 2009 Sep;116(9):1624-9. doi: 10.1016/j.ophtha.2009.04.054.

PMID:
19729097
8.

Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Mii A, Shimizu A, Kaneko T, Fujita E, Fukui M, Fujino T, Utsumi K, Yamaguchi H, Tajika K, Tsuchiya S, Iino Y, Katayama Y, Fukuda Y.

Pathol Int. 2011 Sep;61(9):518-27. doi: 10.1111/j.1440-1827.2011.02704.x. Epub 2011 Jul 12.

PMID:
21884301
9.

Alterations of hemostatic parameters in the early development of allogeneic hematopoietic stem cell transplantation-related complications.

Han Y, Zhu L, Sun A, Lu X, Hu L, Zhou L, Ren Y, Hu X, Wu X, Wang Z, Ruan C, Wu D.

Ann Hematol. 2011 Oct;90(10):1201-8. doi: 10.1007/s00277-011-1273-5. Epub 2011 Jun 15.

10.

Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects.

Terrier B, Delmas Y, Hummel A, Presne C, Glowacki F, Knebelmann B, Combe C, Lesavre P, Maillard N, Noël LH, Patey-Mariaud de Serre N, Nusbaum S, Radford I, Buzyn A, Fakhouri F.

Nephrol Dial Transplant. 2007 May;22(5):1369-76. Epub 2007 Jan 25.

PMID:
17255123
11.

A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.

Conrad R, Remberger M, Cederlund K, Ringdén O, Barkholt L.

Haematologica. 2008 Feb;93(2):265-72. doi: 10.3324/haematol.11672.

12.

[Clinical analysis of late-onset nephrotic syndrome after allogenic hematopoietic stem cell transplantation].

Luo XD, Liu QF, Ning J, Wei YQ, Fan ZP, Zhang Y, Sun J.

Zhonghua Yi Xue Za Zhi. 2007 Dec 11;87(46):3280-3. Chinese.

PMID:
18396625
13.

Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens.

Yamasaki S, Heike Y, Mori S, Fukuda T, Maruyama D, Kato R, Usui E, Koido K, Kim S, Tanosaki R, Tobinai K, Teshima T, Takaue Y.

Transpl Infect Dis. 2008 Jul;10(4):252-9. doi: 10.1111/j.1399-3062.2007.00291.x. Epub 2008 Jan 9.

PMID:
18194371
14.

Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.

Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Jin JY, Lee JW, Kim CC.

Biol Blood Marrow Transplant. 2009 Jun;15(6):704-17. doi: 10.1016/j.bbmt.2009.02.010. Epub 2009 Apr 9.

15.

Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation.

Clave E, Busson M, Douay C, Peffault de Latour R, Berrou J, Rabian C, Carmagnat M, Rocha V, Charron D, Socié G, Toubert A.

Blood. 2009 Jun 18;113(25):6477-84. doi: 10.1182/blood-2008-09-176594. Epub 2009 Mar 3.

16.

Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantation.

Farina L, Carniti C, Dodero A, Vendramin A, Raganato A, Spina F, Patriarca F, Narni F, Benedetti F, Olivieri A, Corradini P.

Haematologica. 2009 May;94(5):654-62. doi: 10.3324/haematol.2008.000273. Epub 2009 Apr 18.

17.

Renal pathology in hematopoietic cell transplantation recipients.

Troxell ML, Pilapil M, Miklos DB, Higgins JP, Kambham N.

Mod Pathol. 2008 Apr;21(4):396-406. doi: 10.1038/modpathol.3801011. Epub 2008 Jan 25.

18.

Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.

Fuji S, Kim SW, Fukuda T, Mori S, Yamasaki S, Morita-Hoshi Y, Ohara-Waki F, Heike Y, Tobinai K, Tanosaki R, Takaue Y.

Biol Blood Marrow Transplant. 2008 May;14(5):510-7. doi: 10.1016/j.bbmt.2008.02.008.

19.

Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.

Lanino E, Rondelli R, Locatelli F, Messina C, Pession A, Balduzzi A, Favre C, Santarone S, Rabusin M, Pollichieni S, Cesaro S, Dini G; Franca Fagioli for the AIEOP-HSCT Group..

Biol Blood Marrow Transplant. 2009 Jun;15(6):741-8. doi: 10.1016/j.bbmt.2009.03.004. Epub 2009 Apr 8.

20.

Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.

Ayuk F, Diyachenko G, Zabelina T, Wolschke C, Fehse B, Bacher U, Erttmann R, Kröger N, Zander AR.

Biol Blood Marrow Transplant. 2008 Aug;14(8):913-9. doi: 10.1016/j.bbmt.2008.05.023.

Supplemental Content

Support Center